Current Medicinal Chemistry - Central Nervous System Agents

Preface [Hot Topic: Cannabinoid Receptors (Guest Editor: Maria L. Lopez-Rodriguez)]
pp. i-i(1)
Author: Maria L. Lopez-Rodriguez

The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
pp. 155-160(6)
Authors: Maria L. Lopez-Rodriguez; Silvia Ortega-Gutierrez

Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain
pp. 161-174(14)
Author: Christopher J. Fowler

Involvement of the Endocannabinoid System in Motor Disorders
pp. 175-182(8)
Authors: J. J. Fernandez-Ruiz; I. Lastres-Becker; A. Cabranes; E. de Lago; J. A. Ramos

Involvement of the Endogenous Opioid System in Cannabinoid Responses
pp. 183-193(11)
Authors: Olga Valverde; Patricia Robledo; Rafael Maldonado

The Potential Role of the Endocannabinoid System in the Control of Multiple Scleorsis
pp. 195-202(8)
Authors: David Baker; Gareth Pryce

Serotonin 5-HT7 Receptor Antagonists
pp. 203-214(12)
Authors: M. L. Lopez-Rodriguez; B. Benhamu; M. J. Morcillo; E. Porras; J. L. Lavandera; L. Pardo